Boehringer Ingelheim wins jury verdict in Zantac retrial in Illinois

An Illi­nois ju­ry ruled in fa­vor of Boehringer In­gel­heim in Zan­tac lit­i­ga­tion brought by two prostate can­cer pa­tients, the com­pa­ny con­firmed.

The ver­dict fol­lowed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.